Top Industry Leaders in the Lower GI Series Market
Aidoc, an Israeli AI startup, receives FDA clearance for its AI-powered LungVision solution, capable of analyzing Chest X-rays and CT scans for abnormalities. This paves the way for similar AI applications in the Lower GI Series Market, potentially improving accuracy and efficiency in detecting digestive diseases.
Viz.ai, a US company, partners with University Hospitals Cleveland Medical Center to develop AI algorithms for identifying colorectal polyps during barium enemas. This collaboration aims to significantly reduce misdiagnosis and false positives, leading to improved patient outcomes.
Siemens Healthineers introduces the Artis zee XP system with XperC mobile CT scanner, providing high-resolution imaging during fluoroscopic procedures like barium enemas. This mobile technology enhances flexibility and comfort for patients and healthcare professionals.
Ology Bioservices and Exact Sciences are developing non-invasive stool-based DNA tests for colorectal cancer screening. While not a direct replacement for barium enemas, these alternatives offer convenient options for at-home testing and early detection.
List of Lower GI Series Key Companies in the Market
- Eisai (US)
- Cadila Pharmaceuticals
- PeaceHealth
- Purdue Pharma L.P.
- Alfa Wassermann
- NOVADAQ
- Mount Sinai Beth Israel
- AstraZeneca
- Ironwood Pharmaceuticals Inc.